Serum Cathepsin K levels are not suitable to differentiate women with chronic bone disorders such as osteopenia and osteoporosis from healthy pre- and postmenopausal women

Maturitas

Volumn 71, Issue 2, 2012, Pages 169-172

  Adolf, Daniela ^a   Wex, Thomas ^a   Jahn, Oliver ^a   Riebau, Christian ^a   Halangk, Walter ^a   Klose, Silke ^a   Westphal, Sabine ^a   Amthauer, Holger ^a   Winckler, Stephan ^a   Piatek, Stefan ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Bone mineral density; Cathepsin K; Osteoporosis

Indexed keywords

CATHEPSIN K;

ADULT; ARTICLE; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; ENZYME BLOOD LEVEL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OSTEOPENIA; OSTEOPOROSIS; POSTMENOPAUSE; PREMENOPAUSE; VALIDITY;

ADULT; AGED; AGED, 80 AND OVER; AREA UNDER CURVE; BIOLOGICAL MARKERS; BONE DENSITY; BONE DISEASES, METABOLIC; BONE RESORPTION; CATHEPSIN K; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; POSTMENOPAUSE; PREMENOPAUSE; REFERENCE VALUES; ROC CURVE; YOUNG ADULT;

EID: 84855795440     PISSN: 03785122     EISSN: 18734111     Source Type: Journal    
DOI: 10.1016/j.maturitas.2011.11.024     Document Type: Article

References (14)

1. P.D. Delmas, R. Eastell, P. Garnero, M.J. Seibel, and J. Stepan Committee of Scientific Advisors of the International Osteoporosis Foundation. The use of biochemical markers of bone turnover in osteoporosis Osteoporos Int Suppl. 6 2000 S2 S17
2. P. Garnero New biochemical markers of bone turnover IBMS BoneKey 5 2008 84 102
3. F. Pagani, C.M. Francucci, and L. Moro Markers of bone turnover: biochemical and clinical perspectives J Endocrinol Invest 28 2005 8 13
4. B.R. Troen The role of Cathepsin K in normal bone resorption Drug News Perspect 17 2004 19 28 (Pubitemid 38419368)
5. T. Inaoka, G. Bilbe, O. Ishibashi, K. Tezuka, M. Kumegawa, and T. Kokubo Molecular cloning of human cDNA for cathepsin K: novel cystein protease predominantly expressed in bone Biochem Biophys Res Commun 206 1995 89 96
6. B.D. Gelb, G. Shi, H.A. Chapman, and R.J. Desnick Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency Science 273 1996 1236 1238
7. P. Saftig, E. Hunziker, and O. Wehmeyer Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K deficient mice Proc Natl Acad Sci USA 95 1998 13453 13458 (Pubitemid 28522993)
8. G. Holzer, H. Noske, T. Lang, L. Holzer, and U. Willinger Soluble cathepsin K: A novel marker for the prediction of nontraumatic fractures? J Lab Clin Med 146 2005 13 17 (Pubitemid 40982014)
9. C. Meier, U. Meinhardt, and J.R. Greenfield Serum cathepsin K concentrations reflect osteoclastic activity in woman with postmenopausal osteoporosis and patients with Paget's disease Clin Lab 52 2006 1 10 (Pubitemid 43245859)
10. M. Munoz-Torres, R. Reyes-Garcia, and P. Mezquita-Raya Serum cathepsin K as a marker of bone metabolism in postmenopausal women treated with alendronate Maturitas 63 2009 188 192
11. K. Henriksen, L.B. Tanko, P. Qvist, P.D. Delmas, C. Christiansen, and M.A. Karsdal Assessment of osteoclast number and function: application in the development of new and improved treatment modalities for bone diseases Osteoporos Int 18 2007 681 685 (Pubitemid 46525540)
12. WHO. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO Tech Rep 1994; Series 843:1-129.
13. K. Kershan-Schindl, G. Hawa, S. Kudlacek, W. Woloszcuk, and P. Pietschmann Serum levels of cathepsin K decrease with age in both women and men Exp Gerontol 40 2005 532-525
14. M. Skoumal, G. Haberhauer, G. Kolarz, G. Hawa, W. Woloszuk, and A. Klingler Serum Cathepsin K levels of patients with longstanding rheumatoid arthritis: correlation with radiological destruction Arthritis Res Ther 7 2005 R65 R70